Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Berberine inhibits chemotherapy-exacerbated ovarian cancer stem cell-like characteristics and metastasis through GLI1
Yawei Zhao, Xuehan Yang, Jingtong Zhao, et al.
European Journal of Pharmacology (2021) Vol. 895, pp. 173887-173887
Closed Access | Times Cited: 17

Showing 17 citing articles:

Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review
Ruo-Gu Xiong, Siyu Huang, Si-Xia Wu, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4523-4523
Open Access | Times Cited: 84
Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents
Mehrdad Hashemi, Motahare Sadat Ayat Mirdamadi, Yasmin Talebi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106568-106568
Open Access | Times Cited: 70
The function of natural compounds in important anticancer mechanisms
Yang Nan, Hongchan Su, Bo Zhou, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 41
PARD3 drives tumorigenesis through activating Sonic Hedgehog signalling in tumour-initiating cells in liver cancer
Junyu Wu, Hor‐Yue Tan, Yau-Tuen Chan, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 8
Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies
Mahshid Deldar Abad Paskeh, Shafagh Asadi, Amirhossein Zabolian, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11669-11669
Open Access | Times Cited: 34
Berberine and berberine nanoformulations in cancer therapy: Focusing on lung cancer
Chou‐Yi Hsu, Harikumar Pallathadka, Jitendra Gupta, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 8, pp. 4336-4350
Closed Access | Times Cited: 5
Metal-based nanoplatforms for enhancing the biomedical applications of berberine: current progress and future directions
Isaac Baidoo, Paromita Sarbadhikary, Heidi Abrahamse, et al.
Nanomedicine (2025), pp. 1-18
Open Access
Therapeutic Application of Berberine: a Consolidated Review
Techi Mana, Oinam Bidyalaxmi Devi, Yengkhom Disco Singh
Current Pharmacology Reports (2023) Vol. 9, Iss. 5, pp. 329-340
Closed Access | Times Cited: 11
Berberine inhibits metastasis of ovarian cancer by blocking lipid metabolism, alleviating aging of adipose tissue and increasing tumor infiltrating immune cells
Xiaojie Zhang, Bing Xiong, Yujie Cheng, et al.
Translational Oncology (2025) Vol. 56, pp. 102380-102380
Closed Access
cRGD-modified nanoparticles of multi-bioactive agent conjugate with pH-sensitive linkers and PD-L1 antagonist for integrative collaborative treatment of breast cancer
Chenming Zou, Yuepeng Tang, Ping Zeng, et al.
Nanoscale Horizons (2023) Vol. 8, Iss. 7, pp. 870-886
Closed Access | Times Cited: 9
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy
Melania Lo Iacono, Miriam Gaggianesi, Paola Bianca, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 6996-6996
Open Access | Times Cited: 9
Berberine inhibits the proliferation of pancreatic cancer cells by targeting pancreatic cancer stem cells through regulating EMT signaling pathway
MENGMENG LIU, Pan Yue, XUFENG TAO, et al.
Biocell (2022) Vol. 46, Iss. 10, pp. 2257-2265
Open Access | Times Cited: 3
Overview of the signaling pathways involved in metastasis: An intriguing story-tale of the metastatic journey of ovarian cancer cells
Rükset Attar, Tahira Panah, Mirna Azalea Romero, et al.
Cellular and Molecular Biology (2021) Vol. 67, Iss. 3, pp. 212-223
Open Access | Times Cited: 4
Systematic screening of protein-coding gene expression identified VWF as a potential key regulator in anthracycline-based chemotherapy-exacerbated metastasis of breast cancer
Yawei Zhao, Meihui He, Lianzhi Cui, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
A Comprehensive Review Highlighting the Prospects of Phytonutrient Berberine as an Anticancer Agent
Shafiul Haque, Darin Mansor Mathkor, Sajad Ahmad Bhat, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 39, Iss. 1
Closed Access
Polycomb Repressor Complex 1 (PRC1) in ovarian cancer: a scoping literature review
Jessica L. Floyd, Kristen DeSanto, Benjamin G. Bitler, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 202, pp. 104456-104456
Closed Access
A nanoscale natural drug delivery system for targeted drug delivery against ovarian cancer: action mechanism, application enlightenment and future potential
Yi Li, Qian Shen, Feng Lu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Enhancing chemo-immunotherapy in triple-negative breast cancer: Co-delivery of doxorubicin and berberine using nanoparticles to downregulate PD-L1 and eliminate cancer stem cells
Yonghui Shi, Linhui Cao, Wenxia Zhao, et al.
International Journal of Pharmaceutics (2024), pp. 125134-125134
Closed Access
Page 1

Scroll to top